PIC Therapeutics
Yagmur Kan currently serves as a Senior Scientist at PIC Therapeutics, a position she has held since February 2023. With a Ph.D. from Stony Brook University, her research primarily focuses on the biochemistry of non-receptor tyrosine kinases and their implications in disease.
Her earlier research experiences include enriching internships at esteemed institutions such as the UCL Cancer Institute in the UK, Erasmus MC in the Netherlands, and Bilkent University in Turkiye, providing her with valuable insights into cancer research and molecular biology.
Yagmur earned her B.Sc. in Molecular Biology and Genetics from Bilkent University in Turkiye. Additionally, she was an AFS-YES intercultural exchange scholar in the US, sponsored by the US Department of State. Currently, she volunteers at her local AFS, facilitating orientations for outgoing American exchange students and assisting in the cultural adaptation of foreign students in Massachusetts, New Hampshire, and Rhode Island.
PIC Therapeutics
1 followers
PIC Therapeutics is a biotechnology company focused on fundamentally changing how cancer is treated by developing a new generation of therapeutics based on the modulation of RNA translation.